|
|
Post by kite on Nov 4, 2019 9:06:18 GMT -5
WESTLAKE VILLAGE, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it has achieved the second of four specified development milestones under its licensing and collaboration agreement with United Therapeutics for the development and commercialization of a dry powder formulation of treprostinil. Treprostinil Technosphere (“TreT”) is an investigational product currently being evaluated in clinical trials for the treatment of pulmonary arterial hypertension. Pursuant to the agreement, MannKind is eligible to earn additional milestone payments up to $25 million upon the achievement of other defined development milestones. MannKind will also be entitled to receive low double-digit royalties on net sales of TreT.
|
|
|
|
Post by sla55 on Nov 4, 2019 9:06:48 GMT -5
investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-second-125-million-milestone-payment-unitedMannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics WESTLAKE VILLAGE, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it has achieved the second of four specified development milestones under its licensing and collaboration agreement with United Therapeutics for the development and commercialization of a dry powder formulation of treprostinil. Treprostinil Technosphere (“TreT”) is an investigational product currently being evaluated in clinical trials for the treatment of pulmonary arterial hypertension. Pursuant to the agreement, MannKind is eligible to earn additional milestone payments up to $25 million upon the achievement of other defined development milestones. MannKind will also be entitled to receive low double-digit royalties on net sales of TreT.
|
|
|
|
Post by centralcoastinvestor on Nov 4, 2019 9:06:57 GMT -5
|
|
|
|
Post by porkini on Nov 4, 2019 9:15:29 GMT -5
|
|
|
|
Post by porkini on Nov 4, 2019 9:19:18 GMT -5
|
|
|
|
Post by LongMNKD on Nov 4, 2019 9:24:08 GMT -5
great! anyone know what the milestone was?
|
|
|
|
Post by bill on Nov 4, 2019 9:25:27 GMT -5
The link says $12.5 million
|
|
|
|
Post by LongMNKD on Nov 4, 2019 9:28:52 GMT -5
yeah.. but for doing what? what milestone did they reach?
|
|
|
|
Post by boca1girl on Nov 4, 2019 9:44:21 GMT -5
yeah.. but for doing what? what milestone did they reach? I don’t remember the milestones being publicly defined. Someone suggested that this one was for the manufacturing line recently completed. |
|
|
|
Post by cjm18 on Nov 4, 2019 9:46:19 GMT -5
But the rumor sell the news. If there is any more news.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 4, 2019 12:07:12 GMT -5
yeah.. but for doing what? what milestone did they reach? Please do some research. Stop being lazy |
|
|
|
Post by rockstarrick on Nov 4, 2019 12:14:14 GMT -5
great! anyone know what the milestone was? It was for MNKD’s obligation with regards to TREP-T, perhaps the completion of the manufacturing space at the Danbury plant. Regardless, UTHR appears to be happy with the way things are progressing. Very exciting to have this validation of our TS technology. |
|
|
|
Post by bullorbear on Nov 4, 2019 12:27:31 GMT -5
Reasons and outlook for more payments will likely come up in Wed cc.
|
|
|
|
Post by slugworth008 on Nov 4, 2019 13:49:32 GMT -5
great! anyone know what the milestone was? It was for MNKD’s obligation with regards to TREP-T, perhaps the completion of the manufacturing space at the Danbury plant. Regardless, UTHR appears to be happy with the way things are progressing. Very exciting to have this validation of our TS technology. Me as well - Now if they would pop in for a 5% stake in the company. Oh - I would like that very, very much. |
|
|
|
Post by mytakeonit on Nov 4, 2019 14:35:42 GMT -5
I prefer that MNKD be a stand alone company and not have to follow the rules of others. It gets very cumbersome when there are too many chiefs. I also believe that UTHR is of this thinking also.
But, that's mytakeonit
|
|
